Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DYADIC INTERNATIONAL, INC.

(DYAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Dyadic International : , Syngene to Join Forces for COVID-19 Vaccine Production

05/26/2021 | 09:43am EDT


© MT Newswires 2021
All news about DYADIC INTERNATIONAL, INC.
06/28Dyadic's C1 Production Platform Utilized in ZAPI Study Published in “VA..
GL
06/28Dyadic International, Inc.’s C1 Production Platform Utilized in ZAPI Study Pu..
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell Microcap Value ..
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell 3000E Growth In..
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell 3000 Value Inde..
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell 3000 Index
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell 2000 Dynamic In..
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell 2000 Index
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell 3000E Value Ind..
CI
06/25DYADIC INTERNATIONAL, INC.(NASDAQCM : DYAI) dropped from Russell 3000 Growth Ind..
CI
More news
Financials (USD)
Sales 2021 2,80 M - -
Net income 2021 -11,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 -8,50x
Yield 2021 -
Capitalization 98,4 M 98,4 M -
Capi. / Sales 2021 35,1x
Capi. / Sales 2022 29,8x
Nbr of Employees 6
Free-Float 48,6%
Chart DYADIC INTERNATIONAL, INC.
Duration : Period :
Dyadic International, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DYADIC INTERNATIONAL, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Last Close Price 3,57 $
Average target price 10,00 $
Spread / Average Target 180%
EPS Revisions
Managers and Directors
Mark A. Emalfarb President, Chief Executive Officer & Director
Ping W. Rawson Chief Financial Officer
Michael P. Tarnok Chairman
Ronen Tchelet Vice President-Research & Business Development
Seth J. Herbst Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DYADIC INTERNATIONAL, INC.-33.64%101
MODERNA, INC.233.90%88 312
LONZA GROUP AG24.05%53 538
IQVIA HOLDINGS INC.39.02%47 022
CELLTRION, INC.-25.21%32 170
SEAGEN INC.-16.87%28 525